Bayer Polymers to discontinue Cobalt-polybutadiene (CoBR) production in Marl
Reason for decision: drastic drop in demand for CoBR
Bayer Polymers, a division of Bayer AG, is planning to discontinue the production of Cobalt-polybutadiene (CoBR) at its subsidiary Bayer Buna GmbH in Marl in the first half of 2004. The reason for this decision is primarily the accelerating drop in demand for this rubber product. The CoBR facility has a total capacity of 45,000 metric tons. Some 75 employees will be affected. The company has started an information and consultation process with the works council and in the coming weeks will be working on finding individual solutions for those involved. Bayer Buna GmbH currently employs around 240 people in Marl. The production of EPDM rubber which also takes place in Marl is unaffected.
BR from Marl serves as a general-purpose rubber in tires and, in particular, as a plastics modifier for the manufacture of High Impact Polystyrene (HIPS), which is used in packaging materials and a variety of other applications. Owing to increasing substitution of CoBR by Lithium-polybutadiene (LiBR) in the HIPS application, production volumes have fallen drastically. "Closing the facility is therefore an absolute necessity in view of our strategy to improve profitability. Given the structural changes in the market, we see no possibility of continuing CoBR production in Marl," said Dr. Joachim Grub, Head of BR / Butyl Global Operations at Bayer Polymers.
Bayer Polymers will concentrate its remaining polybutadiene production at its sites in Orange (Texas, USA), Port Jérôme (France) and Dormagen (Germany).
Monsanto Company announced that at a special meeting of shareowners held today, shareowners of the company approved the merger of Monsanto with a wholly owned subsidiary of Bayer Aktiengesellschaft. Under the terms of the merger agreement, Monsanto shareowners will receive $128 per share in ... more
Bayer and Monsanto announced that they signed a definitive merger agreement under which Bayer will acquire Monsanto for USD 128 per share in an all-cash transaction. Monsanto’s Board of Directors, Bayer’s Board of Management and Bayer’s Supervisory Board have unanimously approved the agreem ... more
The Bayer Group made further strategic progress and posted strong earnings growth in the third quarter of 2015. “A few weeks ago we announced changes to our organizational structure. The new organization is aimed at supporting our strategy as a leading Life Science company and putting us in ... more
Bayer Technology Services stands for technological competence throughout the service life of processes or units. We support our customers from the development of innovative products and processes to engineering and construction of units, to operating control and optimization – with courage, ... more
Bayer Corporation, headquartered in Pittsburgh, is a subsidiary of Bayer AG, an international health care, nutrition and innovative materials group based in Leverkusen, Germany. In North America, Bayer had 2006 net sales of 7.8 billion euros and employed 17,200 at year end. Bayer’s three s ... more
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Our products and services are designed to benefit people and improve their quality of life. At the same time we want to create value through innovation, growth and high earni ... more